Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Can smartphone nudges reduce evening snacking in type 2 diabetes? Explore new CGM research, early results, and implications for personalized care.
Read More »When Evening Snacking Strikes, Can a Smartphone Nudge Change What Happens Next?
This Insulin Pump Recall Could Affect More Than Convenience
Learn why MiniMed Flex insulin pumps were recalled, the potential insulin delivery risks, and what affected users should do to stay safe.
Read More »High Altitude, Low Oxygen, Same CGM? Researchers Put Sensor Accuracy to the Test
New research examines CGM accuracy in hypoxia, including Dexcom G6 and FreeStyle Libre performance during reduced oxygen exposure.
Read More »Type 1 Diabetes Care Just Changed: The 2026 ADA/EASD Update Clinicians Need to Know
The type 1 diabetes consensus 2026 expands guidance on AID, cardiovascular risk, obesity, complications, psychosocial care, and new therapies.
Read More »Pump or Smart Pen? A Head-to-Head Trial Finds There May Be More Than One Right Answer
A head-to-head trial compared a smart insulin pen vs AID in adults with type 1 diabetes. See who benefited most and why patient preference still matters.
Read More »Pivot Just Got an FDA Update—Here’s What Actually Changed
The Pivot Insulin Delivery System received a new FDA clearance in September 2026. Learn what changed and what clinicians should know.
Read More »Could CGM Help People With Type 1 Diabetes Live Longer?
Could continuous glucose monitoring do more than improve glucose levels and help prevent hypoglycemia? New research raises that possibility. A large observational study examining CGM use and mortality in people with type 1 diabetes found that starting continuous glucose monitoring was associated with a lower risk of death among older …
Read More »Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?
Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …
Read More »Three Decades of Better Type 1 Diabetes Care: Have Complications Actually Declined?
Three decades of advances in diabetes care have transformed how people with type 1 diabetes manage glucose. Insulin pumps, continuous glucose monitoring (CGM), improved insulin analogs, automated insulin delivery, and earlier screening have all changed daily treatment. However, have these advances actually reduced the long-term complications of type 1 diabetes? …
Read More »Digital Diabetes Coaching: Why an App Alone Isn’t Enough
A diabetes app can track meals, count steps, log glucose, and deliver reminders. However, can an app actually help someone turn all that information into lasting daily habits? A recent randomized controlled trial suggests that digital diabetes coaching, with technology supported by ongoing human guidance, may help bridge that gap. …
Read More »